|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xue C, Hu Z, Jiang W, Zhao Y, Xu F, Huang
Y, Zhao H, Wu J, Zhang Y, Zhao L, et al: National survey of the
medical treatment status for non-small cell lung cancer (NSCLC) in
China. Lung Cancer. 77:371–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar
|
|
6
|
Feng B, Zhang K, Wang R and Chen L:
Non-small-cell lung cancer and miRNAs: novel biomarkers and
promising tools for treatment. Clin Sci (Lond). 128:619–634. 2015.
View Article : Google Scholar
|
|
7
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalia M: Biomarkers for personalized
oncology: Recent advances and future challenges. Metabolism.
64(Suppl 1): S16–S21. 2015. View Article : Google Scholar
|
|
9
|
Zhang Y, Yang Q and Wang S: MicroRNAs: A
new key in lung cancer. Cancer Chemother Pharmacol. 74:1105–1111.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang R, Wang ZX, Yang JS, Pan X, De W and
Chen LB: MicroRNA-451 functions as a tumor suppressor in human
non-small cell lung cancer by targeting ras-related protein 14
(RAB14). Oncogene. 30:2644–2658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu X, Sempere LF, Ouyang H, Memoli VA,
Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, et al:
MicroRNA-31 functions as an oncogenic microRNA in mouse and human
lung cancer cells by repressing specific tumor suppressors. J Clin
Invest. 120:1298–1309. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao Z, Liu J, Wang C, Wang Y, Jiang Y and
Guo M: MicroRNA-25 regulates small cell lung cancer cell
development and cell cycle through cyclin E2. Int J Clin Exp
Pathol. 7:7726–7734. 2014.
|
|
13
|
Tanaka N, Toyooka S, Soh J, Kubo T,
Yamamoto H, Maki Y, Muraoka T, Shien K, Furukawa M, Ueno T, et al:
Frequent methylation and oncogenic role of microRNA-34b/c in
small-cell lung cancer. Lung Cancer. 76:32–38. 2012. View Article : Google Scholar
|
|
14
|
Harada H, Taniguchi T and Tanaka N: The
role of interferon regulatory factors in the interferon system and
cell growth control. Biochimie. 80:641–650. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xi H, Eason DD, Ghosh D, Dovhey S, Wright
KL and Blanck G: Co-occupancy of the interfearon regulatory element
of the class II transactivator (CIITA) type IV promoter by
interferon regulatory factors 1 and 2. Oncogene. 18:5889–5903.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen YJ, Wu H, Zhu JM, Li XD, Luo SW, Dong
L, Liu TT and Shen XZ: MicroRNA-18a modulates P53 expression by
targeting IRF2 in gastric cancer patients. J Gastroenterol Hepatol.
31:155–63. 2016. View Article : Google Scholar
|
|
17
|
Sakai T, Mashima H, Yamada Y, Goto T, Sato
W, Dohmen T, Kamada K, Yoshioka M, Uchinami H, Yamamoto Y and
Ohnishi H: The roles of interferon regulatory factors 1 and 2 in
the progression of human pancreatic cancer. Pancreas. 43:909–916.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choo A, Palladinetti P, Holmes T, Basu S,
Shen S, Lock RB, O'Brien TA, Symonds G and Dolnikov A: siRNA
targeting the IRF2 transcription factor inhibits leukaemic cell
growth. Int J Oncol. 33:175–183. 2008.PubMed/NCBI
|
|
19
|
Nicolini A, Carpi A and Rossi G: Cytokines
in breast cancer. Cytokine Growth Factor Rev. 17:325–337. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Liu DP, Chen PP, Koeffler HP, Tong
XJ and Xie D: Involvement of IFN regulatory factor (IRF)-1 and
IRF-2 in the formation and progression of human esophageal cancers.
Cancer Res. 67:2535–2543. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xi H and Blanck G: Interferon regulatory
factor-2 point mutations in human pancreatic tumors. Int J Cancer.
87:803–808. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dykxhoorn DM: MicroRNAs and metastasis:
Little RNAs go a long way. Cancer Res. 70:6401–6406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hummel R, Hussey DJ and Haier J:
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in
different tumour types. Eur J Cancer. 46:298–311. 2010. View Article : Google Scholar
|
|
25
|
Zhao Y, Wei Q, Hu L, Chen F, Hu Z, Heist
RS, Su L, Amos CI, Shen H and Christiani DC: Polymorphisms in
MicroRNAs are associated with survival in non-small cell lung
cancer. Cancer Epidemiol Biomarkers Prev. 23:2503–2511. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo M, Weng Y, Tang J, Hu M, Liu Q, Jiang
F, Yang D, Liu C, Zhan X, Song P, et al: MicroRNA-450a-3p represses
cell proliferation and regulates embryo development by regulating
Bub1 expression in mouse. PLoS One. 7:e479142012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Castellano L, Giamas G, Jacob J, Coombes
RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman
J, et al: The estrogen receptor-alpha-induced microRNA signature
regulates itself and its transcriptional response. Proc Natl Acad
Sci USA. 106:15732–15737. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brockhausen J, Tay SS, Grzelak CA,
Bertolino P, Bowen DG, d'Avigdor WM, Teoh N, Pok S, Shackel N,
Gamble JR, et al: miR-181a mediates TGF-β-induced hepatocyte EMT
and is dysregulated in cirrhosis and hepatocellular cancer. Liver
Int. 35:240–253. 2015. View Article : Google Scholar
|
|
29
|
Du L and Pertsemlidis A: microRNA
regulation of cell viability and drug sensitivity in lung cancer.
Expert Opin Biol Ther. 12:1221–1239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du L, Schageman JJ, Irnov, Girard L,
Hammond SM, Minna JD, Gazdar AF and Pertsemlidis A: MicroRNA
expression distinguishes SCLC from NSCLC lung tumor cells and
suggests a possible pathological relationship between SCLCs and
NSCLCs. J Exp Clin Cancer Res. 29:752010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Masumi A, Ito M, Mochida K, Hamaguchi I,
Mizukami T, Momose H, Kuramitsu M, Tsuruhara M, Takizawa K, Kato A
and Yamaguchi K: Enhanced RIG-I expression is mediated by
interferon regulatory factor-2 in peripheral blood B cells from
hepatitis C virus-infected patients. Biochem Biophys Res Commun.
391:1623–1628. 2010. View Article : Google Scholar
|
|
32
|
Ciccaglione AR, Stellacci E, Marcantonio
C, Muto V, Equestre M, Marsili G, Rapicetta M and Battistini A:
Repression of interferon regulatory factor 1 by hepatitis C virus
core protein results in inhibition of antiviral and
immunomodulatory genes. J Virol. 81:202–214. 2007. View Article : Google Scholar :
|
|
33
|
Ikushima H, Negishi H and Taniguchi T: The
IRF family transcription factors at the interface of innate and
adaptive immune responses. Cold Spring Harb Symp Quant Biol.
78:105–116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cui L, Deng Y, Rong Y, Lou W, Mao Z, Feng
Y, Xie D and Jin D: IRF-2 is over-expressed in pancreatic cancer
and promotes the growth of pancreatic cancer cells. Tumour Biol.
33:247–255. 2012. View Article : Google Scholar
|
|
35
|
Connett JM, Badri L, Giordano TJ, Connett
WC and Doherty GM: Interferon regulatory factor 1 (IRF-1) and IRF-2
expression in breast cancer tissue microarrays. J Interferon
Cytokine Res. 25:587–594. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y, Liu D, Chen P, Koeffler HP, Tong X
and Xie D: Negative feedback regulation of IFN-gamma pathway by IFN
regulatory factor 2 in esophageal cancers. Cancer Res.
68:1136–1143. 2008. View Article : Google Scholar : PubMed/NCBI
|
